Nanosonics Receives FDA De Novo Clearance for CORIS
Filed with ASX · · 1 page · English
Watch Nanosonics' latest callNanosonics (ASX:NAN) Q2 2026 Earnings Call · Replay · Feb 23Read the transcript of Nanosonics (ASX:NAN) Q2 2026 Earnings CallEarlier from Nanosonics
- 2025 Half Year Financial Results
- Appendix 4D and Half Year Accounts
- H1 FY25 trading update
- Response to ASX Query
- S&P DJI Announces September 2024 Quarterly Rebalance
Later from Nanosonics
- Response to ASX Price Query
- Nanosonics launches trophon3 and trophon2 Plus software
- US FDA clearance received for next generation trophon
- Appendix 4E
- Nanosonics to commence $20 million share buy-back program
Follow Nanosonics into a list and get an email when it puts out news.
Follow Nanosonics